on Immunic AG
Immunic Announces Participation in July Investor Conferences
Immunic, Inc. (Nasdaq: IMUX), a biotechnology firm advancing novel oral treatments for neurologic ailments, disclosed its involvement in key investor conferences this July. From July 14-15, company executives will engage in one-on-one meetings at the Leerink Partners Therapeutics Forum in Boston. The team includes CEO Erik Lundgren, President Jason Tardio, and CMO Dr. Michael A. Panzara.
On July 16, at the B. Riley Securities Mind, Muscle & Vision Summit, also in Boston, Lundgren, Tardio, and Panzara will partake in a fireside chat. Additionally, they will conduct individual investor sessions. Finally, the team will attend the LifeSci Capital SF Biotech Forum on July 23 in San Francisco.
R. P.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Immunic AG news